Categories AlphaGraphs, Analysis, Earnings, Other Industries

Earnings preview: Cronos could see momentum in Q2

Cronos Group Inc. (NASDAQ: CRON) is scheduled to report second quarter 2019 earnings results on Thursday, August 8, before market open. Analysts expect the company to report a loss of $0.02 per share on revenue of $5.6 million.

The cannabis industry hit a rough patch in the past few months with companies delivering weak earnings and facing bad press over violations and warnings. However, things seem to be picking up now. Despite a few setbacks, it seems there are still growth opportunities in the cannabis market.

cronos group Q1 2019 earnings results

Cronos has been making several efforts to take advantage of these opportunities. The Toronto-based company entered into a cannabis concentrate supply agreement with MediPharm Labs in May. Last month, Cronos agreed to purchase an 84,000 sq.ft. fermentation and manufacturing facility in Canada, which will enable it to produce cultured cannabinoids on a large scale.

Cronos also entered into a deal with Heritage Cannabis Holdings for filling and packaging vaporizers for the Canadian cannabis adult-use and medical market. The deal has an annual potential value of $35 million.

On Friday, Cronos announced the acquisition of four of Redwood Holding Group’s operating subsidiaries for approx. $300 million. Redwood produces and markets cannabidiol-infused skincare and other consumer products in the US under the brand Lord Jones.

Tobacco giant Altria (NYSE: MO) made a $1.8 billion investment in Cronos last year and holds a 45% stake in the cannabis company. It will be interesting to watch how these partnerships and investments pan out for Cronos.

Also see: Aphria Q4 2019 Earnings Report

In the first quarter of 2019, Cronos more than doubled its revenues to CAD6.5 million but narrowly missed estimates. The company also reported a profit of CAD0.48 per share when Wall Street had expected a loss.

Also Read:  Dollar General (DG) headed for a busy second half amid stable pandemic sales

Cronos’ shares gained 111% in the past one year but over the past one month, they fell 17%. The stock climbed over 5% on Friday over news of the Redwood acquisition.

Cronos’ peer Aphria Inc. (NYSE: APHA) reported better-than-expected fourth quarter 2019 earnings results on Thursday, with a revenue growth of 969% year-over-year to CAD128.6 million. Adjusted net loss was CAD0.02 per share.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

COVID-19 drove retailers up the digital path years ahead than anticipated

Earlier we looked into how, during the COVID-19 pandemic, retailers saw changing trends in terms of their assortments and how the acceleration of online shopping led many of them to

Snowflake (SNOW) creates a record as the most successful software IPO ever; stock more than doubles

Data is at the heart of business innovation. Recognizing this trend, companies are seeking ways to transform their businesses by capturing, analyzing, and mobilizing data. The public cloud is becoming

Adobe (ADBE) sees new tailwinds as virtual shift gathers steam

The second half has been highly rewarding for design software maker Adobe Inc. (NASDAQ: ADBE) amid stable demand for digital content solutions. The company has remained unaffected by the virus-related

Tags

Top